Latest in Cholesterol
Sort by
1 items
-
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.Business - CNBC - 15 hours ago